Dosage, plasms concentration and antiarrhythmic effect of procainamide in sustained-release tablets.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D005260:Female; D006207:Half-Life; D006801:Humans; D008297:Male; D008875:Middle Aged; D011342:Procainamide / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use; D011343:Procaine / Q000009:adverse effects
D003692:Delayed-Action Preparations; D011343:Procaine; D011342:Procainamide